Evidence map›Paper›PMID 39763898›Full record

ArticlebioRxiv : the preprint server for biology2024

Cellular cartography reveals mouse prostate organization and determinants of castration resistance.

Hanbyul Cho, Yuping Zhang, Jean C Tien, Rahul Mannan, Jie Luo, Sathiya Pandi Narayanan, Somnath Mahapatra, Jing Hu, Greg Shelley, Gabriel Cruz and 9 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Hanbyul ChoMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Yuping ZhangMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Jean C TienMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Rahul MannanMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Jie LuoMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Sathiya Pandi NarayananMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Somnath MahapatraMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Jing HuMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Greg ShelleyDepartment of Urology, University of Michigan, Ann Arbor, MI, 48109.
Gabriel CruzMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Miriam ShahineMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Lisha WangMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Fengyun SuMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Rui WangMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Xuhong CaoMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Saravana Mohan DhanasekaranMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Evan T KellerDepartment of Pathology, University of Michigan, Ann Arbor, MI, 48109.
Sethuramasundaram PitchiayaMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, 48109.

Funding

Tissue/InformaticsP50CA186786 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Ganesh S Palapattu · 2014 to 2026
$27.6M
Exploring Precision Oncology: From Gene Fusions to lncRNAsR35CA231996 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHINNAIYAN, ARUL M · 2018 to 2024
$6.4M
Michigan-VUMC Biomarker Characterization CenterU2CCA271854 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jeffrey John Tosoian · 2022 to 2026
$5.4M
NCI NIH HHS P50 CA186786NCI NIH HHS R35 CA231996NCI NIH HHS U2C CA271854
6 · The paper itself

Abstract

Inadequate response to androgen deprivation therapy (ADT) frequently arises in prostate cancer, driven by cellular mechanisms that remain poorly understood. Here, we integrated single-cell RNA sequencing, single-cell multiomics, and spatial transcriptomics to define the transcriptional, epigenetic, and spatial basis of cell identity and castration response in the mouse prostate. Leveraging these data along with a meta-analysis of human prostates and prostate cancer, we identified cellular orthologs and key determinants of ADT response and resistance. Our findings reveal that mouse prostates harbor lobe-specific luminal epithelial cell types distinguished by unique gene regulatory modules and anatomically defined androgen-responsive transcriptional programs, indicative of divergent developmental origins. Androgen-insensitive, stem-like epithelial populations - resembling human club and hillock cells - are notably enriched in the urethra and ventral prostate but are rare in other lobes. Within the ventral prostate, we also uncovered two additional androgen-responsive luminal epithelial cell types, marked by Pbsn or Spink1 expression, which align with human luminal subsets and may define the origin of distinct prostate cancer subtypes. Castration profoundly reshaped luminal epithelial transcriptomes, with castration-resistant luminal epithelial cells activating stress-responsive and stemness programs. These transcriptional signatures are enriched in tumor cells from ADT-treated and castration-resistant prostate cancer patients, underscoring their likely role in driving treatment resistance. Collectively, our comprehensive cellular atlas of the mouse prostate illuminates the importance of lobe-specific contexts for prostate cancer modeling and reveals potential therapeutic targets to counter castration resistance.

Indexed as

Androgen SignallingBiological Sciences - Medical SciencesCastration Resistant Prostate cancerSingle-cell ATAC SequencingSingle-cell MultiomicsSingle-cell RNA SequencingSpatial TranscriptomicsStemnessStress Response

Identifiers

PMID39763898
PMCPMC11703157

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.